MedPath

Evaluation on the effectiveness and safety of COVID19 immunization in children with underlying disease

Not Applicable
Recruiting
Conditions
Injury, poisoning and certain other consequences of external causes
Registration Number
KCT0007637
Lead Sponsor
Korea University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
330
Inclusion Criteria

Among outpatients 5-15 years old who have underlying diseases such as autoimmune disease, chronic kidney disease, or immunosuppressant taking autoimmune suppressants who visit Seoul National University Children's Hospital, patients who have received a COVID-19 vaccine.

Exclusion Criteria

- Children without underlying medical conditions
- Children who have never been vaccinated against COVID-19
- When the child or parent does not consent to participate in the study
- If the foreign parent is the guardian who has difficulty understanding the explanation and consent form in Korean

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Adverse Drug Event
Secondary Outcome Measures
NameTimeMethod
COVID-19 infection after vaccination
© Copyright 2025. All Rights Reserved by MedPath